Recently, BAHEAL Pharmaceutical Group has reached a strategic cooperation agreement with COSMED Pharmaceutical Co, Ltd. (hereinafter referred to as COSMED). The agreement states that Qingdao Lebao Health Technology Co. Ltd. under the BEHEAL Pharmaceutical Group (hereinafter referred to as Lebao Health) will become the general agent of COSMED soluble micro needle stick in China. The agreement was signed by Chinese representative Mr. Li Zhenyu, general manager of Lebao Health, and Japanese representative Prof. Kamiyama Fumio, president of COSMED. Meanwhile, Mr. Fu Gang, president of BAHEAL Pharmaceutical Group, Mr. Xu Xiaoyang, president of Lebao Health, and Dr. Ying-shu Quan, co-founder of COSMED all participated in the signing conference and exchanged opinions about further cooperation and development.

Chinese representative Mr. Li Zhenyu, general manager of Lebao Health (first from the left side) and Japanese counterpart Prof. Kamiyama Fumio (first from the right side) are signing the agreement.

      Mr. Li Zhenyu, general manager of Lebao Health, thinks that based on the overall stable China-Japan relation, Lebao Health and COSMED should grasp the two-way historical opportunity of supply-side structural reform and consumption upgrade and give a full play to their industrial advantages respectively. Based on the respect for each other's core values, they should innovate the win-win cooperation model to introduce the pioneering noninvasive soluble micro needle stick into the Chinese market, which can contribute greatly to the development of the medical cosmetology industry.

Prof. Kamiyama Fumio, president of COSMED, said, "NSMNIT has been applied in the global market for many years and yielded remarkable effects. We have established long-term cooperation with many internationally well-known enterprises, such as Shiseido and L'Oreal. COSMED has always been seeking the best partner with the hope to better promote NSMNIT. We attach great importance to the Chinese market and we are honored to cooperate with BAHEAL Pharmaceutical Group."

Group photo of the participants in the signning ceremony

       COSMED is a professional firm, which is committed to the development of transdermal absorption drugs, cosmetics, viscosity material and basic research devices. Taking the relative scientific research of Kyoto medicine science and pharmaceutical institution as the technical foundation, the company has obtained outstanding achievements in the clinical application of NSMNIT, diabetes treatment, new type of influenza vaccine, medical cosmetology, etc. The company has won more than 40 international patent authorization, and its leading development of NSMNIT has won the top science and technology award of Japan.

      In 2008, COSMED pioneered the local care products made of hyaluronic acid (hyaluronic acid micro needle membrane), and developed the anti-aging cosmetics brand "QUANIS" according to the market demand by integrating the unique NSMNIT.

      Through the 30-year research, the new concept anti-aging skin care product can be regarded as the product with the greatest breakthrough in the cosmetology field relying on the noninvasive micro needle injection technology. The commercial promotion of high quality product into broader consumer market is the perfect combination of economic benefits and social responsibility for the enterprise. Looking forward into the future, BAHEAL Pharmaceutical Group and COSMED will continue to keep the in-depth cooperation, lead the cutting-edge development in medical cosmetology, and introduce more influential products with greater breakthroughs, so as to bring more good news for the beauty lovers.

Prof. Kamiyama Fumio, QUANIS technology developer, visits BAHEAL Pharmaceutical Group

        This strategic cooperation is not only the grand-new expansion of BAHEAL Pharmaceutical Group in medical cosmetology but also the extension of BAHEAL to provide a healthy life service. On the never-ceasing rapid development rail, BAHEAL aims to provide the whole society with better medical brand commercialization platform and service and healthier living and working environment, using its professional management to optimize health industry resources and improve the quality of public life.